Sun Pharmaceutical Industries Sees 10.55% Surge in Open Interest to 88,556 Contracts

Sun Pharmaceutical Industries Ltd (SUNPHARMA) has experienced a significant increase in open interest today, reflecting heightened trading activity. The latest open interest stands at 88,556 contracts, up from the previous figure of 80,108, marking a change of 8,448 contracts or a 10.55% increase. This surge in open interest coincides with a trading volume of 29,382 contracts, indicating robust market engagement. In terms of price performance, Sun Pharma has outperformed its sector by 0.68%, with a stock price that has remained within a narrow range of Rs 12.3. The stock is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a positive trend in its price trajectory. Additionally, the delivery volume on October 23 reached 18.73 lakh shares, reflecting a 59.15% increase compared to the 5-day average delivery volume, which underscores rising investor participation. With a market capitalization of Rs 4,07,215.13 crore, Sun Pharmaceutical Industries continues to maintain a strong position within the Pharmaceuticals & Biotechnology sector. The notable increase in open interest and trading volume highlights the stock's active market presence, providing a clear picture of its current trading dynamics.